HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LIMITED
发明人:
申请号：
EP17738289.2
公开号：
EP3402536A4
申请日:
2017.01.12
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Radiolabeled compounds which are erlotinib analogs that feature a radioactive halogen and processes of preparing same are disclosed. Uses of these radiolabeled compounds in radioimaging, for identifying and monitoring a level, distribution and/or mutational status of deregulated EGFR, and/or in radiotherapy, are also disclosed.
